RT Journal Article
T1 Angioprevention of Urologic Cancers by Plant-Derived Foods.
A1 García-Caballero, Melissa
A1 Torres-Vargas, José Antonio
A1 Marrero Capitán, Ana Dácil
A1 Martínez-Póveda, Beatriz Amparo
A1 Medina-Torres, Miguel Ángel
A1 Rodríguez-Quesada, Ana María
K1 Aparato urinario - Cáncer - Prevención
K1 Sustancias fitoquímicas
AB The number of cancer cases worldwide keeps growing unstoppably, despite the undeniableadvances achieved by basic research and clinical practice. Urologic tumors, including some asprevalent as prostate, bladder or kidney tumors, are no exceptions to this rule. Moreover, the factthat many of these tumors are detected in early stages lengthens the duration of their treatment, witha significant increase in health care costs. In this scenario, prevention offers the most cost-effectivelong-term strategy for the global control of these diseases. Although specialized diets are not theonly way to decrease the chances to develop cancer, epidemiological evidence support the role ofcertain plant-derived foods in the prevention of urologic cancer. In many cases, these plants are richin antiangiogenic phytochemicals, which could be responsible for their protective or angiopreventiveproperties. Angiogenesis inhibition may contribute to slow down the progression of the tumor at verydifferent stages and, for this reason, angiopreventive strategies could be implemented at differentlevels of chemoprevention, depending on the targeted population. In this review, epidemiologicalevidence supporting the role of certain plant-derived foods in urologic cancer prevention are presented,with particular emphasis on their content in bioactive phytochemicals that could be used inthe angioprevention of cancer.
PB MDPI
YR 2022
FD 2022-01-21
LK https://hdl.handle.net/10630/27120
UL https://hdl.handle.net/10630/27120
LA eng
NO n: García-Caballero, M.; Torres-Vargas, J.A.; Marrero, A.D.; Martínez-Poveda, B.; Medina, M.Á.; Quesada, A.R. Angioprevention of Urologic Cancers by Plant-Derived Foods. Pharmaceutics 2022, 14, 256. https://doi.org/10.3390/ pharmaceutics14020256
NO Partial funding for open access charge: Universidad de Málaga.
DS RIUMA. Repositorio Institucional de la Universidad de Málaga
RD 20 ene 2026